Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Advanced Melanoma × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 587 Lymphoma, T-Cell, Cutaneous 104 Keratosis, Actinic 97 Skin Neoplasms 86 Mycosis Fungoides 70 Neoplasms 67 Sezary Syndrome 66 Neoplasm Metastasis 64 Lymphoma, Non-Hodgkin 61 Leukemia, Lymphocytic, Chronic, B-Cell 56 Carcinoma, Non-Small-Cell Lung 56 Lymphoma, Follicular 54 Lymphoma, Large B-Cell, Diffuse 53 Precursor Cell Lymphoblastic Leukemia-Lymphoma 52 Uveal Melanoma 51 Lymphoma, Mantle-Cell 51 Lymphoma, B-Cell, Marginal Zone 51 Lymphoma, Large-Cell, Immunoblastic 50 Burkitt Lymphoma 49 Carcinoma, Basal Cell 48 Lymphoma 47 Hodgkin Disease 46 Lymphoma, Large-Cell, Anaplastic 44 Carcinoma, Renal Cell 43 Multiple Myeloma 39 Immunoblastic Lymphadenopathy 39 Breast Neoplasms 38 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 37 Lymphoma, Extranodal NK-T-Cell 37 Waldenstrom Macroglobulinemia 36

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03407170 2020-07-15

KEYNOTE-161

Merck Sharp & Dohme LLC

Phase 2 Terminated

1 enrolled 3 charts

Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡